METHODOLOGIC ISSUES IN TRIALS OF ANTIEMETICS

被引:26
作者
PATER, JL
WILLAN, AR
机构
关键词
D O I
10.1200/JCO.1984.2.5.484
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:484 / 487
页数:4
相关论文
共 10 条
[1]  
AAPRO MS, 1983, P AN M AM SOC CLIN, V2, P93
[2]  
Artim R., 1983, P AN M AM SOC CLIN, V2, P84
[3]   CROSSOVER EXPERIMENT FOR CLINICAL-TRIALS [J].
BROWN, BW .
BIOMETRICS, 1980, 36 (01) :69-79
[4]   DELTA-9-TETRAHYDROCANNABINOL IN CANCER-CHEMOTHERAPY - RESEARCH PROBLEMS AND ISSUES [J].
CAREY, MP ;
BURISH, TG ;
BRENNER, DE .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (01) :106-114
[5]  
DERSIMONIAN R, 1982, N ENGL J MED, V306, P332
[6]  
ELLERTON J, 1983, P AM SOC CLIN ONCOL, V2, P84
[7]   IMPORTANCE OF BETA, TYPE-II ERROR AND SAMPLE-SIZE IN DESIGN AND INTERPRETATION OF RANDOMIZED CONTROL TRIAL - SURVEY OF 71 NEGATIVE TRIALS [J].
FREIMAN, JA ;
CHALMERS, TC ;
SMITH, H ;
KUEBLER, RR .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (13) :690-694
[8]  
LEVITT M, 1981, P AM ASSOC CANC RES, V22, P422
[9]  
MCDERMED JE, 1983, P AN M AM SOC CLIN, V2, P88
[10]  
TYSON LB, 1983, P AM SOC CLIN ONCOL, V2, P91